Evidence map›Paper›PMID 41969759›Full record

ArticleOpen forum infectious diseases2026

Clinical Characteristics and Outcomes of Bloodstream Infections Caused by Metallo-β-Lactamase-Producing Enterobacterales in Argentina: A Subanalysis of the EMBARCAR Prospective Multicenter Cohort Study.

Ezequiel Cordova, Juan Pablo Balbuena, Analia Mykietiuk, Javier Farina, Marcelo Gañete, Pablo Scapellato, María Inés Lespada, Esteban Nannini, Rosa Contreras, Eleonora Cunto and 16 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Ezequiel CordovaInfectious Diseases Unit (EC, MIL) and Department of Medicine (CS), Hospital Cosme Argerich, Buenos Aires, Argentina.ORCID https://orcid.org/0000-0002-9751-5208
Juan Pablo BalbuenaDepartment of Research and Infectious Diseases Service, Instituto Médico Platense, La Plata, Argentina.ORCID https://orcid.org/0000-0003-0108-2813
Analia MykietiukDepartment of Research and Infectious Diseases Service, Instituto Médico Platense, La Plata, Argentina.
Javier FarinaInfectious Diseases Service, Hospital de Alta Complejidad Cuenca Alta Nestor Kirchner, Cañuelas, Argentina.ORCID https://orcid.org/0000-0002-9521-0849
Marcelo GañeteInfectious Diseases Service, HIGA Evita Lanús, Lanús, Argentina.ORCID https://orcid.org/0000-0001-9475-9322
Pablo ScapellatoInfectious Diseases Service, Hospital Santojanni, Buenos Aires, Argentina.ORCID https://orcid.org/0000-0001-5072-6318
María Inés LespadaInfectious Diseases Unit (EC, MIL) and Department of Medicine (CS), Hospital Cosme Argerich, Buenos Aires, Argentina.
Esteban NanniniInfectious Diseases Service, Sanatorio Británico, Rosario, Argentina.ORCID https://orcid.org/0000-0002-8472-7965
Rosa ContrerasInfectious Diseases Service, Hospital Marcial Quiroga, San Juan, Argentina.ORCID https://orcid.org/0009-0004-5135-6047
Eleonora CuntoIntensive Care Unit, Hospital F J Muñiz, Buenos Aires, Argentina.ORCID https://orcid.org/0000-0003-2658-1299
Laura BarcelonaInfectious Diseases Service, Hospital Bernardo Houssay, Vicente López, Argentina.ORCID https://orcid.org/0000-0002-8991-6386
Fernando PasteranAntimicrobials Service, National Reference Laboratory for Antimicrobials, Department of Bacteriology, Instituto Nacional de Enfermedades Infecciosas, ANLIS "Carlos G. Malbrán", Buenos Aires, Argentina.ORCID https://orcid.org/0000-0001-5840-5869
Claudia SalgueiraInfectious Diseases Service and Infection Control, Sanatorio Anchorena Recoleta, Buenos Aires, Argentina.ORCID https://orcid.org/0009-0003-4158-6255
Martín HojmanInfectious Diseses Unit, Hospital Gral. De Agudos "Bernardino Rivadavia", Buenos Aires, Argentina.ORCID https://orcid.org/0000-0002-6646-5420
Miriam BlancoMicrobiology Laboratory, Hospital El Cruce, Florencio Varela, Argentina.ORCID https://orcid.org/0000-0003-1999-1310
Horacio Lopez AlegreInfectious Diseases Service, HIGA Presidente Perón, Avellaneda, Argentina.ORCID https://orcid.org/0009-0003-3553-802X
William E Cox FernandezInfectious Diseases Service, Sanatorio Privado San José, Buenos Aires, Argentina.ORCID https://orcid.org/0000-0002-2126-7818
Cecilia EzcurraInfectious Diseases Service, Hospital Alemán, Buenos Aires, Argentina.ORCID https://orcid.org/0009-0002-7720-4098
Darío GodoyMicrobiology Laboratory, Hospital El Cruce, Florencio Varela, Argentina.
María A BigliaInfectious Diseases Service, Hospital Quemados "Dr. Arturo Illia", Buenos Aires, Argentina.
María José Lopez FurstInfectious Diseases Unit, Sanatorio Julio Méndez, Buenos Aires, Argentina.
Gustavo MendezDepartment of Medicine, Division of Infectious Diseases, Hospital Escuela de Agudos Dr. Ramón Madariaga, Posadas, Argentina.ORCID https://orcid.org/0000-0003-0514-7004
María F Aguirre RiosInfectious Diseases Service, Hospital César Milstein, Buenos Aires, Argentina.
Javier AltclasInfectious Diseases Service and Infection Control, Sanatorio Trinidad Mitre, Buenos Aires, Argentina.
César SanchezInfectious Diseases Unit (EC, MIL) and Department of Medicine (CS), Hospital Cosme Argerich, Buenos Aires, Argentina.ORCID https://orcid.org/0009-0008-0628-8064
Martin E StryjewskiDepartment of Medicine, Centro de Educación Médica e Investigaciones Clínicas "Norberto Quirno" (CEMIC), Buenos Aires, Argentina.ORCID https://orcid.org/0000-0002-4986-6564

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Bloodstream infections (BSI) caused by metallo-beta-lactamase (MBL)-producing Enterobacterales (E) are associated with high mortality. However, in most Latin American countries there is a lack of clinical and microbiological data on BSI caused by MBL-E. Methods: This preplanned subgroup analysis of the multicenter, observational, prospective EMBARCAR study focused on adult patients with BSI caused by MBL-E in Argentina. Logistic regression adjusted by propensity scores (PS) for the treatment with ceftazidime-avibactam plus aztreonam (CAZ/AVI plus ATM) were used to identify variables associated with mortality. Results: A total of 140 patients with BSI caused by MBL-producing Enterobacterales were included. Median age was 59 years (IQR 46-70), and most patients were male (61%). Most frequent comorbidities were diabetes 23%, class III obesity 19%, and chronic renal failure 19%. Two thirds of patients were hospitalized in critical care units, 60% required mechanical ventilation and 38% presented with shock. Most frequent isolated microorganisms were Conclusions: In summary, BSI due to MBL-producing Enterobacterales resulted in a high mortality rate in our country. The use of CAZ/AVI plus ATM was associated with a decreased mortality. Better access to these antibiotics should be granted.

Indexed as

aztreonambloodstream infectionceftazidime-avibactamenterobacteralesmetallo-β-lactamase

Identifiers

PMID41969759
PMCPMC13069563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.